EV/EBITDA
0.11
-0.01-8.33%
Thu, 20 Feb 2025 23:14:32 GMT
Summary
- As of February 21, 2025, CARA EV/EBITDA is 0.11, with a fall of -0.01 (-8.33%) during the most recent trading day.
- Over the past year, CARA EV/EBITDA has increased by +0.02 (+22.22%).
- CARA EV/EBITDA is now -99.99% below its all-time high of 898.09.
Performance
CARA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CARA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -8.3% | +2.2% | +1.0% |
| 1 m1 month | -21.4% | +18.4% | +10.8% |
| 3 m3 months | -42.1% | +40.3% | +40.7% |
| 6 m6 months | -50.0% | +56.4% | +26.6% |
| ytdytd | +83.3% | -78.2% | -15.8% |
| 1 y1 year | +22.2% | +5.7% | -33.1% |
| 5 y5 years | +101.5% | -101.3% | -97.5% |
CARA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -21.4% | 0.09 | +22.2% | |
| 3 m | 3-month | 0.22 | -50.0% | 0.06 | +83.3% |
| 6 m | 6-month | 0.26 | -57.7% | 0.06 | +83.3% |
| 1 y | 1-year | 0.26 | -57.7% | -0.10 | +210.0% |
| 3 y | 3-year | 0.26 | -57.7% | -9.54 | +101.2% |
| 5 y | 5-year | 188.03 | -99.9% | -9.54 | +101.2% |
| alltime | all time | 898.09 | -100.0% | -282.45 | +100.0% |
Cara Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.11(+83.3%) |
| 2024 | 0.06(+50.0%) |
| 2023 | 0.04(-100.7%) |
| 2022 | -6.05(-16.9%) |
| 2021 | -7.28(-105.6%) |
| 2020 | 130.17(-2063.3%) |
| Date | Value |
|---|---|
| 2019 | -6.63(+2.3%) |
| 2018 | -6.48(-2.1%) |
| 2017 | -6.62(+56.1%) |
| 2016 | -4.24(-76.8%) |
| 2015 | -18.25(+80.7%) |
| 2014 | -10.10 |
FAQ
- What is Cara Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Cara Therapeutics?
- What is CARA EV/EBITDA year-to-date change?
- What is Cara Therapeutics EV/EBITDA year-on-year change?
What is Cara Therapeutics EV/EBITDA?
The current EV/EBITDA of CARA is 0.11
What is the all time high EV/EBITDA for Cara Therapeutics?
Cara Therapeutics all-time high EV/EBITDA is 898.09
What is CARA EV/EBITDA year-to-date change?
Cara Therapeutics EV/EBITDA has changed by +0.05 (+83.33%) since the beginning of the year
What is Cara Therapeutics EV/EBITDA year-on-year change?
Over the past year, CARA EV/EBITDA has changed by +0.02 (+22.22%)